• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人脾素(hSP)的合成及其对尿毒症患者受损T淋巴细胞和B淋巴细胞免疫效应的研究

Synthesis of human splenin (hSP) and examination of its immunological effects on the impaired T- and B-lymphocytes in uremic patients.

作者信息

Abiko T, Sekino H

机构信息

Kidney Research Laboratory, Sendai, Japan.

出版信息

Chem Pharm Bull (Tokyo). 1990 Feb;38(2):487-91. doi: 10.1248/cpb.38.487.

DOI:10.1248/cpb.38.487
PMID:2337963
Abstract

Human splenin (hSP) was synthesized by assembling eight peptide fragments followed by deprotection with 1M trifluoromethanesulfonic acid-thioanisole (molar ratios, 1:1) in trifluoroacetic acid in the presence of m-cresol and dimethylselenium. Finally, the deprotected peptide was incubated with dithiothreitol to reduce sulfoxide on the methionine side chain. Incubation of peripheral lymphocytes isolated from uremic patients with the synthetic hSP showed an enhancing effect on the reduced B-lymphocytes, but had no restoring effect on the impaired blastogenic response of T-lymphocytes.

摘要

人脾素(hSP)通过组装八个肽片段合成,随后在间甲酚和二甲基硒存在下,于三氟乙酸中用1M三氟甲磺酸 - 硫代苯甲醚(摩尔比1:1)进行脱保护。最后,将脱保护的肽与二硫苏糖醇一起孵育,以还原甲硫氨酸侧链上的亚砜。用合成的hSP孵育人尿毒症患者分离的外周淋巴细胞,结果显示对减少的B淋巴细胞有增强作用,但对受损的T淋巴细胞增殖反应无恢复作用。

相似文献

1
Synthesis of human splenin (hSP) and examination of its immunological effects on the impaired T- and B-lymphocytes in uremic patients.人脾素(hSP)的合成及其对尿毒症患者受损T淋巴细胞和B淋巴细胞免疫效应的研究
Chem Pharm Bull (Tokyo). 1990 Feb;38(2):487-91. doi: 10.1248/cpb.38.487.
2
Synthesis of [Glu34]human splenin (hSP) and examination of its immunological effect on the reduced B-lymphocytes of uremic patients.[Glu34]人脾素(hSP)的合成及其对尿毒症患者B淋巴细胞减少的免疫效应研究
Chem Pharm Bull (Tokyo). 1989 Feb;37(2):391-6. doi: 10.1248/cpb.37.391.
3
Syntheses and effects of human splenin (hSP) fragment 32-48 and an analog on the reduced B-lymphocytes of uremic patients.人脾素(hSP)片段32 - 48及其类似物对尿毒症患者B淋巴细胞减少的合成及影响
Chem Pharm Bull (Tokyo). 1989 Sep;37(9):2472-6. doi: 10.1248/cpb.37.2472.
4
Synthesis of [Phe(4F)3]thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients.
Bioorg Med Chem. 1995 Oct;3(10):1369-75. doi: 10.1016/0968-0896(95)00121-v.
5
Synthesis of deacetyl-thymosin beta 12 and examination of its immunological effects on the impaired T and B lymphocytes in uremic patients.去乙酰胸腺素β12的合成及其对尿毒症患者受损T和B淋巴细胞免疫作用的研究
Biotechnol Ther. 1993;4(3-4):221-37.
6
Synthesis of a thymosin beta 4-like peptide, deacetyl-thymosin beta Xen4, and its restorative effect on depressed lymphocyte blastogenic response to phytohemagglutinin (PHA) in uremic patients.
Chem Pharm Bull (Tokyo). 1989 Sep;37(9):2467-71. doi: 10.1248/cpb.37.2467.
7
Synthesis of human thymopoietin (hTP) and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients.人胸腺生成素(hTP)的合成及其对尿毒症患者T淋巴细胞增殖反应受损的免疫效应研究。
Chem Pharm Bull (Tokyo). 1988 Jul;36(7):2506-16. doi: 10.1248/cpb.36.2506.
8
Synthesis of [I-NaI3]] thymopoietin II and examination of its immunological effect on the uremic T-lymphocytes.[I-NaI3]胸腺生成素II的合成及其对尿毒症T淋巴细胞免疫效应的研究。
Mediators Inflamm. 2000;9(3-4):201-6. doi: 10.1080/09629350020002930.
9
Synthesis of rat parathymosin alpha fragment 1-28 and examination of its inhibitory activity towards the restoring activity of thymosin alpha 1 on the impaired T-lymphocytes of uremic patients.大鼠胸腺素α片段1-28的合成及其对胸腺素α1恢复尿毒症患者受损T淋巴细胞活性的抑制活性研究。
Chem Pharm Bull (Tokyo). 1991 Oct;39(10):2647-52. doi: 10.1248/cpb.39.2647.
10
Synthesis of deacetylthymosin beta 11 and its effect on the impaired T-lymphocytes of a uremic patient with common variable immunodeficiency.去乙酰胸腺素β11的合成及其对一名患有常见变异型免疫缺陷的尿毒症患者受损T淋巴细胞的影响。
Biotechnol Appl Biochem. 1988 Dec;10(6):576-88.